To examine how CXCR4 overexpression would impact on antitumor immunity, we evaluated graft-versus-tumor (GvT) responses mediated by allogeneic (B6, H-2b) T cells following transfer to tumor-bearing BALB/c (H-2d) recipients. Here, CXCR4 is linked to neoplasm.